Daiwa Securities Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6K | Hold |
692
| – | – | ﹤0.01% | 1145 |
|
2025
Q1 | $5K | Hold |
692
| – | – | ﹤0.01% | 1129 |
|
2024
Q4 | $5K | Hold |
692
| – | – | ﹤0.01% | 1161 |
|
2024
Q3 | $5K | Hold |
692
| – | – | ﹤0.01% | 1165 |
|
2024
Q2 | $4K | Hold |
692
| – | – | ﹤0.01% | 1199 |
|
2024
Q1 | $4K | Hold |
692
| – | – | ﹤0.01% | 1211 |
|
2023
Q4 | $4K | Hold |
692
| – | – | ﹤0.01% | 1210 |
|
2023
Q3 | $5K | Hold |
692
| – | – | ﹤0.01% | 1148 |
|
2023
Q2 | $5K | Hold |
692
| – | – | ﹤0.01% | 1168 |
|
2023
Q1 | $6K | Hold |
692
| – | – | ﹤0.01% | 1128 |
|
2022
Q4 | $8K | Hold |
692
| – | – | ﹤0.01% | 1116 |
|
2022
Q3 | $9K | Hold |
692
| – | – | ﹤0.01% | 1122 |
|
2022
Q2 | $7K | Buy |
692
+167
| +32% | +$1.69K | ﹤0.01% | 1140 |
|
2022
Q1 | $9K | Hold |
525
| – | – | ﹤0.01% | 1136 |
|
2021
Q4 | $7K | Sell |
525
-88
| -14% | -$1.17K | ﹤0.01% | 1160 |
|
2021
Q3 | $9K | Buy |
613
+281
| +85% | +$4.13K | ﹤0.01% | 1143 |
|
2021
Q2 | $5K | Hold |
332
| – | – | ﹤0.01% | 1065 |
|
2021
Q1 | $3K | Hold |
332
| – | – | ﹤0.01% | 1099 |
|
2020
Q4 | $2K | Sell |
332
-654
| -66% | -$3.94K | ﹤0.01% | 1110 |
|
2020
Q3 | $3K | Buy |
986
+117
| +13% | +$356 | ﹤0.01% | 1104 |
|
2020
Q2 | $2K | Hold |
869
| – | – | ﹤0.01% | 1139 |
|
2020
Q1 | $2K | Hold |
869
| – | – | ﹤0.01% | 1143 |
|
2019
Q4 | $3K | Buy |
869
+172
| +25% | +$594 | ﹤0.01% | 1132 |
|
2019
Q3 | $2K | Hold |
697
| – | – | ﹤0.01% | 1109 |
|
2019
Q2 | $3K | Hold |
697
| – | – | ﹤0.01% | 1107 |
|
2019
Q1 | $6K | Buy |
697
+153
| +28% | +$1.32K | ﹤0.01% | 1053 |
|
2018
Q4 | $4K | Hold |
544
| – | – | ﹤0.01% | 1058 |
|
2018
Q3 | $4K | Hold |
544
| – | – | ﹤0.01% | 1074 |
|
2018
Q2 | $3K | Hold |
544
| – | – | ﹤0.01% | 1107 |
|
2018
Q1 | $3K | Buy |
+544
| New | +$3K | ﹤0.01% | 1091 |
|